Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand

Trini Mathew, MD MPH

CEO, HealthTAMCycle³ PLLC
Clinical Professor, Dept of Medicine, Oakland University William Beaumont School of Medicine, MI, United States

Dr. Mathew completed her medical school, MD with honors, from Tver State Medical Academy, Russia and her residency and chief residency in Internal Medicine from Jacobi Medical Center, Bronx, NY. She subsequently pursued her Infectious Diseases (ID) fellowship at Beth Israel Deaconess Medical Center, affiliated with Harvard Medical School, Boston, and also completed her MPH through Harvard School of Public Health. During her ID fellowship, she worked with Partners In Health (PIH), Boston and Tomsk, Siberia, Russia on the intersection of TB, Alcohol Use Disorders and HIV.

Dr. Mathew volunteered with the Infectious Diseases Society of America (IDSA) for 6 years on the IDSA Public Health committee and represented IDSA at Capitol Hill briefings on Immunizations. She has served as a member of the IDSA Inclusion, Diversity, Access and Equity task Force (2020- 2021). In 2022, Dr. Mathew was invited to serve a three-year term on the IDSA Leadership Development Committee. Dr. Mathew is also a member of The Society for Healthcare Epidemiology of America (SHEA) and volunteers on SHEA Community Based Healthcare Epidemiologists Task Force and was appointed Vice Chair in 2020 and Chair in 2021 (a two-year term), of the Public Policy and Government Affairs Committee of SHEA. In this role, she has also advocated for and published policy papers on pandemic preparedness and interacted with staff on Senate HELP Committee on PREVENT Pandemics Act. In 2022, she was appointed a member of the new SHEA Diversity, Equity and Inclusion Committee. Dr. Mathew has also served as a member of the Advisory Committee for Elimination of TB, Connecticut Department of Public Health and participated in a Work group on TB screening in Health Care Workers, as part of the National TB Controller’s Association. Her initial question on utility of annual TB screening of US healthcare personnel (HCP), led to collaborations and publication of the new US recommendations on TB screening for HCP in US in 2019.

In March 2021, she established an independent consulting firm for providing infection prevention and epidemiology consultations. From 2022-2024, she worked with colleagues at Wayne State University on a grant from MDHHS, providing infection prevention education in skilled nursing facilities in city of Detroit. She collaborated with colleagues at Yale university on a CDC grant award for strengthening infection Prevention (2022-2024).

Dr. Mathew is Clinical Professor, Department of Medicine, School of Medicine at Oakland University William Beaumont (OUWB) and Associate Professor, Wayne State University (adjunct), Michigan
She currently serves as the Medical Director of both Infection Prevention, Control and Epidemiology and Antimicrobial Stewardship Program, Corewell Health, Taylor, Michigan and serves as ID consultant, William Beaumont University Hospital, Royal Oak, Michigan.

Her research interests are preventing health care associated infections, risk mitigation of outbreaks, promoting One Health, optimizing vaccine uptake and integration of IPC and Human Factors Engineering. She is also actively working on improving diversity, equity and inclusion in healthcare settings and recently was reappointed to the OUWB DEI Council 2023-2025 and received the 2024 OUWB Faculty award for excellence in DEI

Disclosure(s): Alphabet Inc: Stocks/Bonds (Public Company); GE Healthcare tech: Stocks/Bonds (Public Company)

Presentation(s):